Efficacy and Safety of Super-hyperfractionation Pulse Radiotherapy Combined With ICIs for Advanced NSCLC
Conditions
Lung Cancer · Immune Checkpoint Inhibitor · Radiotherapy
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
the second affiliated hospital of Army medical university, Chongqing, Chongqing Municipality, China
Jianguo Sun, Chongqing, China
Study leads
Jianguo Sun
Principal Investigator
Department of Oncology, Xinqiao Hospital, Army Medical University